Novel, rare and common pathogenic variants in the CFTR gene screened by high-throughput sequencing technology and predicted by in silico tools.

作者: Stéphanie Villa-Nova Pereira , José Dirceu Ribeiro , Antônio Fernando Ribeiro , Carmen Sílvia Bertuzzo , Fernando Augusto Lima Marson

DOI: 10.1038/S41598-019-42404-6

关键词:

摘要: Cystic fibrosis (CF) is caused by ~300 pathogenic CFTR variants. The heterogeneity of which, challenges molecular diagnosis and precision medicine approaches in CF. Our objective was to identify variants through high-throughput sequencing (HTS) predict the pathogenicity novel 8 silico tools. Two guidelines were followed deduce pathogenicity. A total 169 CF patients had genomic DNA submitted a Targeted Gene Sequencing we identified 63 (three three variants). most frequent alleles were: F508del (n = 192), G542* (n = 26), N1303K (n = 11), R1162* R334W (n = 9). screened classified as follows: 41 – [classified (I) n = 23, (II) n = 6, (III) n = 1, (IV) (IV/V) n = 1 (VI) n = 4]; 14 uncertain significance; seven To suggested classification 6b-16 exon duplication, G646* 3557delA Class I. There concordance among predictors likely for L935Q, cDNA.5808T>A I1427I. Also, Y325F presented two discordant results predictors. HTS analysis can will open door integration into routine clinical practice near future.

参考文章(51)
M. Kellis, B. Wold, M. P. Snyder, B. E. Bernstein, A. Kundaje, G. K. Marinov, L. D. Ward, E. Birney, G. E. Crawford, J. Dekker, I. Dunham, L. L. Elnitski, P. J. Farnham, E. A. Feingold, M. Gerstein, M. C. Giddings, D. M. Gilbert, T. R. Gingeras, E. D. Green, R. Guigo, T. Hubbard, J. Kent, J. D. Lieb, R. M. Myers, M. J. Pazin, B. Ren, J. A. Stamatoyannopoulos, Z. Weng, K. P. White, R. C. Hardison, Defining functional DNA elements in the human genome Proceedings of the National Academy of Sciences of the United States of America. ,vol. 111, pp. 6131- 6138 ,(2014) , 10.1073/PNAS.1318948111
James T Robinson, Helga Thorvaldsdóttir, Wendy Winckler, Mitchell Guttman, Eric S Lander, Gad Getz, Jill P Mesirov, Integrative genomics viewer Nature Biotechnology. ,vol. 29, pp. 24- 26 ,(2011) , 10.1038/NBT.1754
Sherstin Lommatzsch, Robert Aris, Genetics of cystic fibrosis. Seminars in Respiratory and Critical Care Medicine. ,vol. 30, pp. 531- 538 ,(2009) , 10.1055/S-0029-1238911
Céline René, Damien Paulet, Emmanuelle Girodon, Catherine Costa, Guy Lalau, Julie Leclerc, Faïza Cabet-Bey, Thierry Bienvenu, Martine Blayau, Albert Iron, Hervé Mittre, Delphine Feldmann, Caroline Guittard, Mireille Claustres, Marie des Georges, p.Ser1235Arg should no longer be considered as a cystic fibrosis mutation: results from a large collaborative study European Journal of Human Genetics. ,vol. 19, pp. 36- 42 ,(2011) , 10.1038/EJHG.2010.137
Riordan, J. Rommens, B Kerem, N Alon, R Rozmahel, Z Grzelczak, J Zielenski, S Lok, N Plavsic, J. Chou, al. et, Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. ,vol. 245, pp. 1066- 1073 ,(1989) , 10.1126/SCIENCE.2475911
Richard C. Boucher, Cystic fibrosis: a disease of vulnerability to airway surface dehydration Trends in Molecular Medicine. ,vol. 13, pp. 231- 240 ,(2007) , 10.1016/J.MOLMED.2007.05.001
Christine E. Bear, Canhui Li, Norbert Kartner, Robert J. Bridges, Tim J. Jensen, Mohabir Ramjeesingh, John R. Riordan, Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR) Cell. ,vol. 68, pp. 809- 818 ,(1992) , 10.1016/0092-8674(92)90155-6
Ivan A Adzhubei, Steffen Schmidt, Leonid Peshkin, Vasily E Ramensky, Anna Gerasimova, Peer Bork, Alexey S Kondrashov, Shamil R Sunyaev, A method and server for predicting damaging missense mutations Nature Methods. ,vol. 7, pp. 248- 249 ,(2010) , 10.1038/NMETH0410-248